Literature DB >> 11368974

Involvement of enhanced sensitivity of N-methyl-D-aspartate receptors in vulnerability of developing cortical neurons to methylmercury neurotoxicity.

K Miyamoto1, H Nakanishi, S Moriguchi, N Fukuyama, K Eto, J Wakamiya, K Murao, K Arimura, M Osame.   

Abstract

The developing cortical neurons have been well documented to be extremely vulnerable to the toxic effect of methylmercury (MeHg). In the present study, a possible involvement of N-methyl-D-aspartate (NMDA) receptors in MeHg neurotoxicity was examined because the sensitivity of cortical neurons to NMDA neurotoxicity has a similar developmental profile. Rats on postnatal day 2 (P2), P16, and P60 were orally administered MeHg (10 mg/kg) for 7 consecutive days. The most severe neuronal damage was observed in the occipital cortex of P16 rats. When MK-801 (0.1 mg/kg), a non-competitive antagonist of NMDA, was administered intraperitoneally with MeHg, MeHg-induced neurodegeneration was markedly ameliorated. Furthermore, there was a marked accumulation of nitrotyrosine, a reaction product of peroxynitrite and L-tyrosine, after chronic treatment of MeHg in the occipital cortex of P16 rats. The accumulation of nitrotyrosine was also significantly suppressed by MK-801. In the present electrophysiological study, the amplitude of synaptic responses mediated by NMDA receptors recorded in cortical neurons of P16 rats was significantly larger than those from P2 and P60 rats. These observations strongly suggest that a generation of peroxynitrite through activation of NMDA receptors is a major causal factor for MeHg neurotoxicity in the developing cortical neurons. Furthermore, enhanced sensitivity of NMDA receptors may make the cortical neurons of P16 rats most susceptible to MeHg neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11368974     DOI: 10.1016/s0006-8993(01)02281-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder.

Authors:  Josephine Elia; Joseph T Glessner; Kai Wang; Nagahide Takahashi; Corina J Shtir; Dexter Hadley; Patrick M A Sleiman; Haitao Zhang; Cecilia E Kim; Reid Robison; Gholson J Lyon; James H Flory; Jonathan P Bradfield; Marcin Imielinski; Cuiping Hou; Edward C Frackelton; Rosetta M Chiavacci; Takeshi Sakurai; Cara Rabin; Frank A Middleton; Kelly A Thomas; Maria Garris; Frank Mentch; Christine M Freitag; Hans-Christoph Steinhausen; Alexandre A Todorov; Andreas Reif; Aribert Rothenberger; Barbara Franke; Eric O Mick; Herbert Roeyers; Jan Buitelaar; Klaus-Peter Lesch; Tobias Banaschewski; Richard P Ebstein; Fernando Mulas; Robert D Oades; Joseph Sergeant; Edmund Sonuga-Barke; Tobias J Renner; Marcel Romanos; Jasmin Romanos; Andreas Warnke; Susanne Walitza; Jobst Meyer; Haukur Pálmason; Christiane Seitz; Sandra K Loo; Susan L Smalley; Joseph Biederman; Lindsey Kent; Philip Asherson; Richard J L Anney; J William Gaynor; Philip Shaw; Marcella Devoto; Peter S White; Struan F A Grant; Joseph D Buxbaum; Judith L Rapoport; Nigel M Williams; Stanley F Nelson; Stephen V Faraone; Hakon Hakonarson
Journal:  Nat Genet       Date:  2011-12-04       Impact factor: 38.330

Review 2.  Methylmercury: recent advances in the understanding of its neurotoxicity.

Authors:  Michael Aschner; Tore Syversen
Journal:  Ther Drug Monit       Date:  2005-06       Impact factor: 3.681

Review 3.  Neurobehavioural and molecular changes induced by methylmercury exposure during development.

Authors:  Carolina Johansson; Anna F Castoldi; Natalia Onishchenko; Luigi Manzo; Marie Vahter; Sandra Ceccatelli
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

Review 4.  Metallothionein in the central nervous system: Roles in protection, regeneration and cognition.

Authors:  Adrian K West; Juan Hidalgo; Donnie Eddins; Edward D Levin; Michael Aschner
Journal:  Neurotoxicology       Date:  2008-01-19       Impact factor: 4.294

5.  Comparison of alterations in amino acids content in cultured astrocytes or neurons exposed to methylmercury separately or in co-culture.

Authors:  Zhaobao Yin; Jan Albrecht; Tore Syversen; Haiyan Jiang; Marshall Summar; Joao B T Rocha; Marcelo Farina; Michael Aschner
Journal:  Neurochem Int       Date:  2009-01-31       Impact factor: 3.921

6.  Methylmercury Affects the Expression of Hypothalamic Neuropeptides That Control Body Weight in C57BL/6J Mice.

Authors:  Beatriz Ferrer; Tanara Vieira Peres; Alessandra Antunes Dos Santos; Julia Bornhorst; Patricia Morcillo; Cinara Ludvig Gonçalves; Michael Aschner
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

Review 7.  Effects of methylmercury on spinal cord afferents and efferents-A review.

Authors:  Alexandra Colón-Rodríguez; Heidi E Hannon; William D Atchison
Journal:  Neurotoxicology       Date:  2016-12-29       Impact factor: 4.294

Review 8.  Approaches for assessing risks to sensitive populations: lessons learned from evaluating risks in the pediatric population.

Authors:  Ronald N Hines; Dana Sargent; Herman Autrup; Linda S Birnbaum; Robert L Brent; Nancy G Doerrer; Elaine A Cohen Hubal; Daland R Juberg; Christian Laurent; Robert Luebke; Klaus Olejniczak; Christopher J Portier; William Slikker
Journal:  Toxicol Sci       Date:  2009-09-21       Impact factor: 4.849

Review 9.  Methylmercury and brain development: A review of recent literature.

Authors:  Alessandra Antunes Dos Santos; Mariana Appel Hort; Megan Culbreth; Caridad López-Granero; Marcelo Farina; Joao B T Rocha; Michael Aschner
Journal:  J Trace Elem Med Biol       Date:  2016-03-04       Impact factor: 3.849

Review 10.  Neurotoxicity of organomercurial compounds.

Authors:  Coral Sanfeliu; Jordi Sebastià; Rosa Cristòfol; Eduard Rodríguez-Farré
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.